Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.
Saved in:
| Title: | Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. |
|---|---|
| Authors: | Fraticelli L; Laboratory P2S (Health Systemic Process), UR 4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France., Freyssenge J; Research on Healthcare Performance RESHAPE, INSERM U1290, University Claude Bernard Lyon 1, University of Lyon, Lyon, France., Promé-Combel E; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France., Agnellet E; Pharmaceutical Unit, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France., Dargaud Y; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France., Chamouard V; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Pharmaceutical Unit, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France. |
| Source: | JMIR research protocols [JMIR Res Protoc] 2023 Mar 08; Vol. 12, pp. e43091. Date of Electronic Publication: 2023 Mar 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Print ISSN: 1929-0748 (Print) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36884286 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fraticelli+L%22">Fraticelli L</searchLink>; Laboratory P2S (Health Systemic Process), UR 4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Freyssenge+J%22">Freyssenge J</searchLink>; Research on Healthcare Performance RESHAPE, INSERM U1290, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Promé-Combel+E%22">Promé-Combel E</searchLink>; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.<br /><searchLink fieldCode="AU" term="%22Agnellet+E%22">Agnellet E</searchLink>; Pharmaceutical Unit, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.<br /><searchLink fieldCode="AU" term="%22Dargaud+Y%22">Dargaud Y</searchLink>; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.<br /><searchLink fieldCode="AU" term="%22Chamouard+V%22">Chamouard V</searchLink>; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Pharmaceutical Unit, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101599504%22">JMIR research protocols</searchLink> [JMIR Res Protoc] 2023 Mar 08; Vol. 12, pp. e43091. <i>Date of Electronic Publication: </i>2023 Mar 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22JMIR+Publications%22">JMIR Publications </searchLink><i>Country of Publication: </i>Canada <i>NLM ID: </i>101599504 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1929-0748 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219290748%22">19290748 </searchLink><i>NLM ISO Abbreviation: </i>JMIR Res Protoc <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36884286 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2196/43091 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e43091 Titles: – TitleFull: Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fraticelli L – PersonEntity: Name: NameFull: Freyssenge J – PersonEntity: Name: NameFull: Promé-Combel E – PersonEntity: Name: NameFull: Agnellet E – PersonEntity: Name: NameFull: Dargaud Y – PersonEntity: Name: NameFull: Chamouard V IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 03 Text: 2023 Mar 08 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1929-0748 Numbering: – Type: volume Value: 12 Titles: – TitleFull: JMIR research protocols Type: main |
| ResultId | 1 |
